Strides Pharma Ibuprofen Recall
Analysis based on 7 articles · First reported Mar 19, 2026 · Last updated Mar 20, 2026
The recall of Children's Ibuprofen Oral Suspension by Strides Pharma Science could lead to a temporary dip in consumer confidence for over-the-counter children's medications, potentially affecting sales for Strides Pharma Science and Taro Pharmaceutical Industries. The United States — Food and Drug Administration's classification of the recall as Class II suggests a limited but notable impact on public health perception of pharmaceutical safety.
Strides Pharma Science has voluntarily recalled nearly 90,000 bottles of its Children's Ibuprofen Oral Suspension, manufactured for Taro Pharmaceutical Industries, across the United States. The recall was initiated on March 2, 2026, following complaints of a 'gel-like mass and black particles' found in the medicine. The United States — Food and Drug Administration classified this as a Class II recall on March 16, 2026, indicating that exposure to the product may cause temporary or medically reversible adverse health consequences. Consumers are advised to immediately stop using the affected product, which includes specific lot numbers and an expiration date of January 31, 2027.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard